A Study to Evaluate Efficacy & Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Richter's Syndrome;

Clinical trial NCT04939363 · COMPLETED

Trial details

NCT number: NCT04939363
Sponsor: Bnai Zion Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Richter's Syndrome

Start date: 2021-08-08
Primary completion: 2024-10-09
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.